These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Value of an Immediate Intravesical Instillation of Mitomycin C in Patients with Non-muscle-invasive Bladder Cancer: A Prospective Multicentre Randomised Study in 2243 patients. Bosschieter J, Nieuwenhuijzen JA, van Ginkel T, Vis AN, Witte B, Newling D, Beckers GMA, van Moorselaar RJA. Eur Urol; 2018 Feb; 73(2):226-232. PubMed ID: 28705539 [Abstract] [Full Text] [Related]
3. [Management of non invasive bladder cancers. T1Ga urothelial cell carcinoma: benefit of immediate post operative instillation?]. Rouprêt M, Guillotreau J, Irani J, Zerbib M. Prog Urol; 2010 Mar; 20 Suppl 1():S46-9. PubMed ID: 20493444 [Abstract] [Full Text] [Related]
9. The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial. Divrik RT, Yildirim U, Zorlu F, Ozen H. J Urol; 2006 May; 175(5):1641-4. PubMed ID: 16600720 [Abstract] [Full Text] [Related]
10. Delayed healing at transurethral resection of bladder tumour sites after immediate postoperative mitomycin C instillation. Aagaard MF, Mogensen K, Hermann GG. Scand J Urol; 2014 Apr; 48(2):222-4. PubMed ID: 23870006 [Abstract] [Full Text] [Related]
11. Contemporary cost analysis of single instillation of mitomycin after transurethral resection of bladder tumor in a universal health care system. Feifer A, Xie X, Brophy JM, Segal R, Kassouf W. Urology; 2010 Sep; 76(3):652-6. PubMed ID: 20394970 [Abstract] [Full Text] [Related]
13. [Early postoperative mitomycin C instillation: when and how?]. Traxer O, Gattegno B. Prog Urol; 2004 Apr; 14(2):249-51. PubMed ID: 15217151 [Abstract] [Full Text] [Related]
14. [Calcified bladder lesions secondary to the instillation of mitomycin C]. Megias Garrigós J, Pelluch Auladell A, Romero Pérez P, Fernandez García J, Gassó Matoses M, Sánchez Marcos M, Mira Llinarés A. Arch Esp Urol; 1991 Nov; 44(9):1057-60. PubMed ID: 1807206 [Abstract] [Full Text] [Related]
16. Electromotive drug administration with mitomycin C for intravesical treatment of non-muscle invasive transitional cell carcinoma. Kalsi J, Harland SJ, Feneley MR. Expert Opin Drug Deliv; 2008 Jan; 5(1):137-45. PubMed ID: 18095933 [Abstract] [Full Text] [Related]
17. Intravesical thermo-chemotherapy based on conductive heat: a first pharmacokinetic study with mitomycin C in superficial transitional cell carcinoma patients. Milla P, Fiorito C, Soria F, Arpicco S, Cattel L, Gontero P. Cancer Chemother Pharmacol; 2014 Mar; 73(3):503-9. PubMed ID: 24442034 [Abstract] [Full Text] [Related]
18. Intravesical adjuvant therapy using mitomycin C. Islam MA, Bhuiyan ZH, Shameem IA. Mymensingh Med J; 2006 Jan; 15(1):40-4. PubMed ID: 16467761 [Abstract] [Full Text] [Related]
19. Is there an optimal treatment scheme for adjuvant intravesical therapy? Preliminary analysis of an EORTC protocol comparing early and delayed instillation with and without maintenance of either adriamycin or mitomycin-C in patients with superficial transitional carcinoma of the bladder. Kurth KH, Bouffioux C, Sylvester R, de Pauw M. Prog Clin Biol Res; 1988 Jan; 269():525-37. PubMed ID: 3134663 [No Abstract] [Full Text] [Related]
20. Randomized controlled study of the efficacy and safety of continuous saline bladder irrigation after transurethral resection for the treatment of non-muscle-invasive bladder cancer. Onishi T, Sugino Y, Shibahara T, Masui S, Yabana T, Sasaki T. BJU Int; 2017 Feb; 119(2):276-282. PubMed ID: 27444991 [Abstract] [Full Text] [Related] Page: [Next] [New Search]